Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

P-INC: Project Incontinence- Effectiveness of Nursing Recommendations

23 maggio 2018 aggiornato da: Medical University of Graz

Effectiveness of Nursing Recommendations for the Management of Urinary Incontinence in Nursing Homes: a Cluster-randomized Controlled Trial

The international literature emphasizes the vast benefits of the effective implementation of evidence based nursing recommendations in improving patient care processes and enhancing health outcomes. The key role of nurses in the prevention, treatment and care of incontinence is highlighted. Studies have shown that UI is a neglected nursing care problem in Austria e.g. regarding diagnosis and nursing interventions. Nursing recommendations may enhance the frequency of diagnosis, the use of nursing interventions as well as decrease the frequency of daily UI in nursing home residents. Beside that little is known about nursing recommendations implementation regarding urinary incontinence in the nursing home setting, especially in the Austrian context.

The aim of this study is to measure the effectiveness of the implementation of evidence based nursing recommendations regarding UI in Austrian nursing homes.

Panoramica dello studio

Stato

Completato

Descrizione dettagliata

The aim of this study is to measure the effectiveness of the implementation of evidence based nursing recommendations regarding UI in Austrian nursing homes, including three research questions:

  1. What is the statistical difference between the frequency of daily UI in nursing home residents in the intervention group when compared to the control group?
  2. What is the statistical difference between the frequency of documented categorisation of UI (UI diagnosis) in the intervention group (implementation of the nursing recommendations) compared to the control group (standard care)?
  3. What is the statistical difference between the amounts of used nursing interventions in the intervention group compared to the control group?

5. Methods 5.1. Design A three-month cluster-randomized trial will be conducted in nursing homes in Styria and Carinthia.

5.2. Setting All nursing homes in Styria and Carinthia with a capacity ≥ 50 beds registered in a national database [15] will be invited to participate by means of an information flyer and email. With regards to practicability invitation will be started with those nursing homes with the highest number of beds.

5.3. Sample Currently there are 176 nursing homes in Styria and Carinthia with a capacity ≥ 50 beds registered in a national database with a total of 15208 nursing home residents. Through experiences from former projects a low response rate is expected. We assume a response rate of 2% on the nursing home level, amounting to 3 participating nursing homes with 259 residents. Nursing homes that want to participate voluntarily will be contacted via telephone starting at the largest for further inclusion criteria.

Inclusion criteria for nursing home residents are living in the nursing home at the date of baseline measurement and being female and assumed to stay for the whole duration of the study (3 months). Written informed consent from the participating residents or their legal representatives is required.

The nursing interventions are made for women, so we have to focus our sample to women. In Austrian nursing homes about 70% are women.Which means we have a total of 181 female nursing home residents that can be asked for participation.

We know from former studies that 90% of nursing home residents are able and willing to participate in a research study, amounting to an expected total of 163 participants in the 3 remaining nursing homes. We assume that 10% of the residents drop out during the study period. Therefore 147 female residents in the 3 nursing homes are basis for our calculation.

These 3 nursing homes will be randomly assigned (eg. via "Randomizer") to the intervention group and to the control group.

An Intra Class Coefficient (ICC) 0.05 was assumed from the literature. With the "Sample Size Calculator" developed by Campbell et al. (2004) the detectable difference with these fixed sample sizes was calculated.

With an expected cluster size of 49 nursing home residents in 3 clusters and a power of 80 % and a significance level of 0.05 we expect a minimum decrease in the frequency of daily UI from 90% to 55%.

6.0 Ethical considerations This study will be conducted in line with the declaration of Helsinki and the "Good scientific practice" of the Medical University of Graz. Nursing homes can withdraw their participation without stating reasons via telephone and email. Informed consent will be obtained of all participating residents. Residents can withdraw anytime in the study without stating reasons.

The questionnaire is based on the routine nursing care interventions and data regarding UI. Therefore no risk or side effects for the participating residents are expected. Nursing homes in the control group receive the nursing recommendations after the three month study period.

In this study only data will be collected. Therefore names of the residents cannot be traced.

7.0 Data collection including instruments Baseline measurement: The baseline measurement will be conducted to gather data on resident level (Table 1).

Table 1: Collected baseline data including time Collected data Collection time Purpose

  • Participation Baseline
  • Age Baseline Comparing residents
  • Diagnosis Dementia Baseline Comparing residents
  • Care dependency Baseline/6weeks/month Comparing residents
  • Continence status Baseline/6weeks/month Comparing residents

The questionnaire at resident's level is based on the questionnaire "Pflegequalitätserhebung 2.0", which is the Austrian questionnaire of the "International Prevalence Measurement of Care Problems" research project. The Institute of Nursing Science at the Medical University of Graz is member of this research project. Questions concerning the continence status include the presence, use of catheter, staring point, frequency, diagnosis of urinary incontinence and the used nursing interventions for the management of urinary incontinence.

The German version of the Care Dependency Scale (CDS) will be used to measure the degree of care dependency with reference to different needs such as mobility or continence, where lower scores referred to higher levels of care dependency. The CDS sum score of the residents can range from completely care dependent (15-24 points), to a great extent care dependent (25-44 points), partially care dependent (45-59 points), to a limited extent care independent (60-69 points) and up to almost care independent (70-75 points).

Outcome measurement Table 2 shows the collected outcome data, the collection time and purpose. Again the Austrian version of the standardized and tested "International Prevalence Measurement of Care Problems" will be used to collect data on key outcomes, i.e. UI frequency and diagnosis.

Table 2: Collected outcome data including time and purpose Collection time Purpose Frequency of UI Baseline/6 weeks/3 month Intervention effect Diagnosis of UI Baseline/6 weeks/3 month Intervention effect Use of nursing interventions Baseline/6 weeks/3 month Intervention effect

8.0 Data analysis Data analysis via SPSS (Version 23 or higher) will be performed in consultation with the Institute for Medical Informatics, Statistics and Documentation of the Medical University of Graz, Austria, using descriptive statistics and mixed model analyses. According to Sedgwick (2015) and Shah (2011) the analysis will be conducted following "per protocol" as well as "intention to treat" analysis. The "per protocol" analysis will show the effectiveness under study conditions and the "intention to treat" will show the effect of the nursing recommendations in real life nursing practice.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

147

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Styria
      • Graz, Styria, Austria, 8010
        • Institute of Nursing Science

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

60 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sessi ammissibili allo studio

Femmina

Descrizione

Inclusion Criteria:

  • 1. The management of the institution agrees to the random allocation to the intervention or control group.

    2. A clinical guideline including evidence based nursing recommendations related to UI has not been introduced and implemented.

    3. Nursing staff have not received a specialized training in the last 2 years on UI prevention or management.

    4. Less than 5 other major nursing care innovation projects have been implemented during the last two years.

    5. Within the institution there is no specialized nurse employed for the management of incontinence.

Inclusion criteria for nursing home residents are living in the nursing home at the date of baseline measurement and being female and assumed to stay for the whole duration of the study (3 months).

Exclusion Criteria:

-

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: Gruppo di controllo
Assistenza infermieristica di routine
Altro: Intervention group
Evidence based nursing recommendations for the management of urinary incontinence will be introduced.
The intervention group gets the evidence based nursing interventions for the conservative management of urinary incontinence in female nursing homes.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Difference of the frequency of daily urinary incontinence between intervention and control group
Lasso di tempo: 3 month
Collected after 3 Month
3 month

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Difference of nurses diagnoses for urinary incontinence between intervention and control group
Lasso di tempo: 3 Month
Collected after 3 Month
3 Month
Difference between the intervention and control group in the use of nursing interventions
Lasso di tempo: 3 Month
Collected after 3 Month
3 Month

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Manuela Hoedl, BSc, MSc, Medical University of Graz

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

18 aprile 2017

Completamento primario (Effettivo)

2 ottobre 2017

Completamento dello studio (Effettivo)

1 febbraio 2018

Date di iscrizione allo studio

Primo inviato

12 gennaio 2017

Primo inviato che soddisfa i criteri di controllo qualità

23 gennaio 2017

Primo Inserito (Stima)

24 gennaio 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

24 maggio 2018

Ultimo aggiornamento inviato che soddisfa i criteri QC

23 maggio 2018

Ultimo verificato

1 maggio 2018

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi